Your browser doesn't support javascript.
loading
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Morgan, Robert D; Burghel, George J; Flaum, Nicola; Bulman, Michael; Smith, Philip; Clamp, Andrew R; Hasan, Jurjees; Mitchell, Claire L; Salih, Zena; Woodward, Emma R; Lalloo, Fiona; Crosbie, Emma J; Edmondson, Richard J; Wallace, Andrew J; Jayson, Gordon C; Evans, D Gareth R.
Afiliación
  • Morgan RD; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. robert.morgan7@nhs.net.
  • Burghel GJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. robert.morgan7@nhs.net.
  • Flaum N; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.
  • Bulman M; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Smith P; Division of Evolution & Genomic Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Clamp AR; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.
  • Hasan J; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.
  • Mitchell CL; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Salih Z; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Woodward ER; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Lalloo F; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Crosbie EJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Edmondson RJ; Division of Evolution & Genomic Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Wallace AJ; Department of Clinical Genetics, Manchester University NHS Foundation Trust, Manchester, UK.
  • Jayson GC; Department of Clinical Genetics, Manchester University NHS Foundation Trust, Manchester, UK.
  • Evans DGR; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Br J Cancer ; 127(1): 163-167, 2022 07.
Article en En | MEDLINE | ID: mdl-35260807
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Mutación de Línea Germinal Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Mutación de Línea Germinal Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido